A groundbreaking minimally invasive procedure has shown promising results in alleviating knee pain for individuals suffering from osteoarthritis, potentially reducing the necessity for knee ...
Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced positive interim efficacy data from the Phase I stage of its ...